Home › Companies › Treace Medical Concepts, Inc. › 2025-2026

Treace Medical Concepts, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Treace Medical Concepts, Inc.’s Form 8-K, filed May 20, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 5Ballot items
  • 114Asset managers
  • 637Fund votes
  • May 19, 2026Meeting date

Results at a glance

Meeting of May 19, 2026: 5 items on Treace Medical Concepts, Inc.’s Form 8-K, filed May 20, 2026: 3 elected · 2 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Treace Medical Concepts, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Treace Medical Concepts, Inc.

These tallies are Treace Medical Concepts, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 20, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Treace Medical Concepts, Inc. — official shareholder meeting results, meeting held May 19, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Lance A. Berry 33,804,407---- 820,72313,516,432 98%Elected—
Elect Director: Elizabeth S. Hanna 30,856,965---- 3,768,16513,516,432 89%Elected—
Elect Director: Jane E. Kiernan 33,587,226---- 1,037,90413,516,432 97%Elected—
2. Advisory Vote on Executive Compensation 32,785,5051,724,383115,242 --13,516,432 95%Approved—
3. Ratification of Selection of Independent Registered Public Accounting Firm 47,885,305120,733135,524 --0 99.7%Approved—

Source: Treace Medical Concepts, Inc., Form 8-K, filed with the SEC on May 20, 2026 — read the filing on EDGAR.

How asset managers voted at the Treace Medical Concepts, Inc. 2025-2026 meeting

Each item below shows how the 114 asset managers that disclosed a Treace Medical Concepts, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Elizabeth S. Hanna

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 30,856,965WITHHELD: 3,768,165
Details: description as filed, official tally, votes by 39 asset managers

Description as filed by funds: Election of Directors: Elizabeth S. Hanna

Treace Medical Concepts, Inc.’s own tally for this item (“Elect Director: Elizabeth S. Hanna”): 30,856,965 for, 3,768,165 withheld, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected, by the votes indicated below, the following nominees to the Company's Board of Directors to serve as Class II directors for a three-year term of office expiring at the 2029 annual meeting of stockholders or until their respective successors have been duly elected and quali…”
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 39 asset managers below reported 4,273,508 for, 548,325 withheld, 24,930 abstained.

FOR
FOR: 4,273,508ABSTAIN: 24,930WITHHOLD: 548,325
Largest asset managers voting on “Election of Directors: Elizabeth S. Hanna” at Treace Medical Concepts, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,900,7540 3,9851,888For
BlackRock947,3830 00For
Fidelity646,9980 01,900For
Charles Schwab353,8050 00For
FIRST EAGLE FUNDS00 0174,141Withhold
Equitable70,0860 039,240Mixed
TIAA101,0490 00For
Dimensional00 073,680Withhold
QUANTITATIVE MASTER SERIES LLC73,6720 00For
CLEARWATER INVESTMENT TRUST00 068,642Withhold
BRIDGEWAY FUNDS INC00 050,000Withhold
PACE SELECT ADVISORS TRUST00 040,814Withhold
Goldman Sachs39,0040 00For
Lincoln Financial36,2000 00For
Northern Trust00 025,830Withhold
AIG/SunAmerica00 024,503Withhold
Global X23,0700 00For
MASTER INVESTMENT PORTFOLIO19,2390 00For
Pacific Life18,3310 00For
John Hancock00 16,1850Abstain
Nationwide13,8390 00For
Bridge Builder Trust9,4980 00For
Brighthouse00 09,331Withhold
ProShares00 07,912Withhold
DWS00 07,338Withhold

Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.

2. Elect Director: Jane E. Kiernan

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 33,587,226WITHHELD: 1,037,904
Details: description as filed, official tally, votes by 39 asset managers

Description as filed by funds: Election of Directors: Jane E. Kiernan

Treace Medical Concepts, Inc.’s own tally for this item (“Elect Director: Jane E. Kiernan”): 33,587,226 for, 1,037,904 withheld, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected, by the votes indicated below, the following nominees to the Company's Board of Directors to serve as Class II directors for a three-year term of office expiring at the 2029 annual meeting of stockholders or until their respective successors have been duly elected and quali…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 39 asset managers below reported 4,712,000 for, 126,023 withheld, 8,740 abstained.

FOR
FOR: 4,712,000ABSTAIN: 8,740WITHHOLD: 126,023
Largest asset managers voting on “Election of Directors: Jane E. Kiernan” at Treace Medical Concepts, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,902,6470 3,9800For
BlackRock947,3830 00For
Fidelity648,8980 00For
Charles Schwab353,8050 00For
FIRST EAGLE FUNDS174,1410 00For
Equitable70,0860 039,240Mixed
TIAA101,0490 00For
Dimensional00 073,680Withhold
QUANTITATIVE MASTER SERIES LLC73,6720 00For
CLEARWATER INVESTMENT TRUST68,6420 00For
BRIDGEWAY FUNDS INC50,0000 00For
PACE SELECT ADVISORS TRUST40,8140 00For
Goldman Sachs39,0040 00For
Lincoln Financial36,2000 00For
Northern Trust25,8300 00For
AIG/SunAmerica24,5030 00For
Global X23,0700 00For
MASTER INVESTMENT PORTFOLIO19,2390 00For
Pacific Life18,3310 00For
John Hancock16,1850 00For
Nationwide13,8390 00For
Bridge Builder Trust9,4980 00For
Brighthouse00 09,331Withhold
ProShares7,9120 00For
DWS7,3380 00For

Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.

3. Elect Director: Lance A. Berry

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 33,804,407WITHHELD: 820,723
Details: description as filed, official tally, votes by 39 asset managers

Description as filed by funds: Election of Directors: Lance A. Berry

Treace Medical Concepts, Inc.’s own tally for this item (“Elect Director: Lance A. Berry”): 33,804,407 for, 820,723 withheld, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected, by the votes indicated below, the following nominees to the Company's Board of Directors to serve as Class II directors for a three-year term of office expiring at the 2029 annual meeting of stockholders or until their respective successors have been duly elected and quali…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 39 asset managers below reported 4,712,002 for, 126,023 withheld, 8,738 abstained.

FOR
FOR: 4,712,002ABSTAIN: 8,738WITHHOLD: 126,023
Largest asset managers voting on “Election of Directors: Lance A. Berry” at Treace Medical Concepts, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,902,6490 3,9780For
BlackRock947,3830 00For
Fidelity648,8980 00For
Charles Schwab353,8050 00For
FIRST EAGLE FUNDS174,1410 00For
Equitable70,0860 039,240Mixed
TIAA101,0490 00For
Dimensional00 073,680Withhold
QUANTITATIVE MASTER SERIES LLC73,6720 00For
CLEARWATER INVESTMENT TRUST68,6420 00For
BRIDGEWAY FUNDS INC50,0000 00For
PACE SELECT ADVISORS TRUST40,8140 00For
Goldman Sachs39,0040 00For
Lincoln Financial36,2000 00For
Northern Trust25,8300 00For
AIG/SunAmerica24,5030 00For
Global X23,0700 00For
MASTER INVESTMENT PORTFOLIO19,2390 00For
Pacific Life18,3310 00For
John Hancock16,1850 00For
Nationwide13,8390 00For
Bridge Builder Trust9,4980 00For
Brighthouse00 09,331Withhold
ProShares7,9120 00For
DWS7,3380 00For

Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.

4. 2. Advisory Vote on Executive Compensation

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 32,785,505AGAINST: 1,724,383
Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

Treace Medical Concepts, Inc.’s own tally for this item (“2. Advisory Vote on Executive Compensation”): 32,785,505 for, 1,724,383 against — passed, per its Form 8-K filed May 20, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “By the vote stated below, the stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 39 asset managers voting on “APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at Treace Medical Concepts, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,906,6223 00For
BlackRock947,3830 00For
Fidelity648,8980 00For
Charles Schwab353,8050 00For
FIRST EAGLE FUNDS174,1410 00For
Equitable109,3260 00For
TIAA101,0490 00For
Dimensional073,680 00Against
QUANTITATIVE MASTER SERIES LLC73,6720 00For
CLEARWATER INVESTMENT TRUST68,6420 00For
BRIDGEWAY FUNDS INC050,000 00Against
PACE SELECT ADVISORS TRUST40,8140 00For
Goldman Sachs39,0040 00For
Lincoln Financial36,2000 00For
Northern Trust025,830 00Against
AIG/SunAmerica24,5030 00For
Global X23,0700 00For
MASTER INVESTMENT PORTFOLIO19,2390 00For
Pacific Life18,3310 00For
John Hancock16,1850 00For
Nationwide13,8390 00For
Bridge Builder Trust9,4980 00For
Brighthouse00 9,3310Abstain
ProShares7,9120 00For
DWS7,3380 00For

Fund voting reports, all 39 managers: 4,675,034 for, 162,396 against, 9,331 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 88 asset managers voting on “APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at Treace Medical Concepts, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
CIBC Private Wealth Group LLC14,706,8630 00For
BlackRock1,412,6541,130 00For
GEODE CAPITAL MANAGEMENT, LLC812,5350 00For
State Street735,3321,082 00For
ACADIAN ASSET MANAGEMENT LLC692,8380 00For
ARMISTICE CAPITAL, LLC690,0440 00For
Vanguard367,9430 00For
Charles Schwab354,1060 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM316,1240 00For
AQR269,3060 00For
Northern Trust1,420226,132 00Against
Citadel202,4390 00For
First Eagle Investment Management, LLC200,0000 00For
STIFEL NICOLAUS & CO INC \MO\191,2280 00For
Nuveen152,4340 00For
MELLON INVESTMENTS Corp148,8570 00For
Goldman Sachs148,0900 00For
JACOBS LEVY EQUITY MANAGEMENT, INC118,6470 00For
PARADIGM CAPITAL MANAGEMENT INC/NY100,0000 00For
AllianceBernstein64,5500 00For
Dimensional062,605 00Against
Point7253,9610 00For
T. Rowe Price51,2540 00For
BRIDGEWAY CAPITAL MANAGEMENT, LLC050,000 00Against
PARAMETRIC PORTFOLIO ASSOCIATES LLC33,5680 00For

Institutional-manager reports, all 88 managers: 22,127,795 for, 389,084 against. Showing the 25 largest; see all in the interactive database.

5. 3. Ratification of Selection of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.7% Approved · of votes cast

FOR 99.7%
FOR: 47,885,305AGAINST: 120,733
Details: description as filed, official tally, votes by 38 asset managers

Description as filed by funds: Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.

Treace Medical Concepts, Inc.’s own tally for this item (“3. Ratification of Selection of Independent Registered Public Accounting Firm”): 47,885,305 for, 120,733 against — passed, per its Form 8-K filed May 20, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “By the vote stated below, the stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026:”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 38 asset managers below reported 4,768,789 for, 9,331 abstained.

FOR
FOR: 4,768,789ABSTAIN: 9,331
Largest asset managers voting on “Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accountin” at Treace Medical Concepts, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,906,6260 00For
BlackRock947,3830 00For
Fidelity648,8980 00For
Charles Schwab353,8050 00For
FIRST EAGLE FUNDS174,1410 00For
Equitable109,3260 00For
TIAA101,0490 00For
Dimensional73,6800 00For
QUANTITATIVE MASTER SERIES LLC73,6720 00For
BRIDGEWAY FUNDS INC50,0000 00For
PACE SELECT ADVISORS TRUST40,8140 00For
Goldman Sachs39,0040 00For
Lincoln Financial36,2000 00For
Northern Trust25,8300 00For
AIG/SunAmerica24,5030 00For
Global X23,0700 00For
MASTER INVESTMENT PORTFOLIO19,2390 00For
Pacific Life18,3310 00For
John Hancock16,1850 00For
Nationwide13,8390 00For
Bridge Builder Trust9,4980 00For
Brighthouse00 9,3310Abstain
ProShares7,9120 00For
DWS7,3380 00For
SEI6,2000 00For

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

Largest Treace Medical Concepts, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 64,872,976 shares outstanding at the time of that meeting.

Fund voting reports: top Treace Medical Concepts, Inc. shareholders by shares voted on “APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED…”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 2.94%
2BlackRock 1.46%
3Fidelity 1.00%
4Charles Schwab 0.55%
5FIRST EAGLE FUNDS 0.27%
6Equitable 0.17%
7TIAA 0.16%
8Dimensional 0.11%
9QUANTITATIVE MASTER SERIES LLC 0.11%
10CLEARWATER INVESTMENT TRUST 0.11%
Institutional-manager reports: top Treace Medical Concepts, Inc. shareholders by shares voted on “APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED…”, 2025-2026
#Asset manager % of shares outstanding
1CIBC Private Wealth Group LLC 22.67%
2BlackRock 2.18%
3GEODE CAPITAL MANAGEMENT, LLC 1.25%
4State Street 1.14%
5ACADIAN ASSET MANAGEMENT LLC 1.07%
6ARMISTICE CAPITAL, LLC 1.06%
7Vanguard 0.57%
8Charles Schwab 0.55%
9STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 0.49%
10AQR 0.42%

Reported Treace Medical Concepts, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Treace Medical Concepts, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
John T. Treace 19.32% 13G
Neil Gagnon 9.47% 13G
BANK OF AMERICA CORP /DE/ 5.45% 13G
BlackRock 5.15% 13F
Vanguard Group 3.50% 13F
State Street 1.90% 13F
Millennium Management 1.77% 13F
Geode Capital 1.56% 13F
D.E. Shaw 1.30% 13F
Citadel Advisors 1.27% 13F

Percentages above are of 64,872,976 shares outstanding, as reported by Treace Medical Concepts, Inc. on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Treace Medical Concepts, Inc.’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At Treace Medical Concepts, Inc.'s shareholder meeting held May 19, 2026, in the 2025-2026 proxy season, 114 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 637 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED… — Treace Medical Concepts, Inc.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Treace Medical Concepts, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 20, 2026.

Treace Medical Concepts, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.